Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
European Journal of Neurology
|
March 25, 2022
Guilty by association? SARS-CoV-2 antibodies and myelin oligodendrocyte glycoprotein antibody-associated disease
Radu Tanasescu, Markus Reindl
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 26, 2020
Uncovering the underhanded: B-cell depletion therapies and severe viral infections - Commentary on 'Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease'
Radu Tanasescu, Bruno Gran
European Journal of Neurology
|
January 25, 2023
Brain-specific biomarkers: on the winding path to accessibility and clinical relevance
Radu Tanasescu, Didier Leys
European Journal of Neurology
|
October 20, 2022
To predict or not to predict: Multiple sclerosis and B-cell subset-specific genetic risk scores
Radu Tanasescu, Andrew Chan
Current Topics in Behavioral Neurosciences
|
December 5, 2014
Helminth Therapy for MS
Radu Tanasescu, Cris S Constantinescu
Immunobiology
|
February 16, 2010
Cannabinoids and the immune system: an overview
Radu Tanasescu, Cris S Constantinescu
Expert Opinion on Drug Metabolism & Toxicology
|
April 30, 2013
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain
Radu Tanasescu, Cris S Constantinescu
Expert Opinion on Drug Metabolism & Toxicology
|
March 4, 2014
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis
Radu Tanasescu, Cris S Constantinescu
Frontiers in Neurology
|
August 8, 2022
Editorial: Preventing multiple sclerosis
Ruth Dobson, Radu Tanasescu, Bruno Gran
American Journal of Clinical and Experimental Immunology
|
March 25, 2014
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital
Aneesa Mahadeva, Radu Tanasescu, Bruno Gran
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
European Journal of Neurology
|
March 25, 2022
Guilty by association? SARS-CoV-2 antibodies and myelin oligodendrocyte glycoprotein antibody-associated disease
Radu Tanasescu, Markus Reindl
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 26, 2020
Uncovering the underhanded: B-cell depletion therapies and severe viral infections - Commentary on 'Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease'
Radu Tanasescu, Bruno Gran
European Journal of Neurology
|
January 25, 2023
Brain-specific biomarkers: on the winding path to accessibility and clinical relevance
Radu Tanasescu, Didier Leys
European Journal of Neurology
|
October 20, 2022
To predict or not to predict: Multiple sclerosis and B-cell subset-specific genetic risk scores
Radu Tanasescu, Andrew Chan
Current Topics in Behavioral Neurosciences
|
December 5, 2014
Helminth Therapy for MS
Radu Tanasescu, Cris S Constantinescu
Immunobiology
|
February 16, 2010
Cannabinoids and the immune system: an overview
Radu Tanasescu, Cris S Constantinescu
Expert Opinion on Drug Metabolism & Toxicology
|
April 30, 2013
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain
Radu Tanasescu, Cris S Constantinescu
Expert Opinion on Drug Metabolism & Toxicology
|
March 4, 2014
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis
Radu Tanasescu, Cris S Constantinescu
Frontiers in Neurology
|
August 8, 2022
Editorial: Preventing multiple sclerosis
Ruth Dobson, Radu Tanasescu, Bruno Gran
American Journal of Clinical and Experimental Immunology
|
March 25, 2014
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital
Aneesa Mahadeva, Radu Tanasescu, Bruno Gran
Page
of 9